This episode currently has no reviews.
Submit ReviewAs we count down to the Fed’s decision on interest rates this week, our market guest says don’t fear high rates, embrace them! He tells us why, and what he’s buying against this backdrop – including one name that’s out of character for him. Plus, Elon Musk makes a surprise visit to China as Tesla clears a major hurdle in that market. Is this the catalyst that could turn things around for the beaten-down EV maker? We’ll discuss. Plus, this name offers a unique way to trade the GLP-1 diet drug craze, but the company’s product spans across various sectors. The CEO joins us exclusively ahead.
This episode currently has no reviews.
Submit ReviewThis episode could use a review! Have anything to say about it? Share your thoughts using the button below.
Submit Review